FDA embraces potential of AI to advance medicine and streamline operations
- FDA has been preparing for challenges and potential of AI for a long time
- AI can enable advances in medical products and food safety
- Over 1,000 AI-related submissions for drugs, devices, etc. have been received by FDA
- FDA is exploring using AI to streamline internal operations and regulatory processes
- Paper reaffirms commitment to safe, ethical AI in medical products